Las Vegas, NV -- (SBWIRE) -- 10/04/2013 -- PennyStockEarnings team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks. Our Today’s Focus is on: American Assets Trust, Inc (NYSE:AAT), Raptor Pharmaceutical Corp. (NASDAQ:RPTP), Umpqua Holdings Corp (NASDAQ:UMPQ), Pacific Biosciences of California (NASDAQ:PACB
American Assets Trust, Inc (NYSE:AAT) managed to keep its gain at 2.45% on above-normal volume of 1.28M shares. The stock settled at $31.77 after floating in a range of $31.55 to $32.11. Its latest price has reached market capitalization of $1.28 billion. Its 52-week range has been $24.87 to $36.26. American Assets Trust, Inc. is a full-service vertically integrated and self-administered real estate investment trust (REIT).
For How Long AAT will fight for Profitability? Read This Trend Analysis report
Raptor Pharmaceutical Corp. (NASDAQ:RPTP) traded up on a volume of 1.28 million, higher than its standard daily volume. Shares have gained 0.41% to $14.76. Over the last twelve months, the stock has gained 65.47% and faced a worst price of $4.35. Raptor Pharmaceuticals Corp. (RPC), formerly TorreyPines Therapeutics, Inc., is an early development-stage Company.
For How Long RPTP’s Gloss will Attract Investors? Find out via this report
Umpqua Holdings Corp (NASDAQ:UMPQ) settled -0.37% lower at $16.31 on below -normal volume of 1.27M shares during the last trading day. The stock has its 12-month high at $17.48 and 52-week low price was $11.17. It traded in a range of $16.18 to $16.40 during the last trading day. Umpqua Holdings Corporation (Umpqua) is a financial holding company. Umpqua has two principal operating subsidiaries, Umpqua Bank (the Bank) and Umpqua Investments, Inc. (Umpqua Investments).
Will UMPQ Get Buyers Even After The Recent Rally? Find Out Here
In the last trading session, Pacific Biosciences of California (NASDAQ:PACB) was down on high volume, trading at a volume of 1.27M shares versus its average daily volume of 1.12 million shares. At $5.53, the stock has attained market capitalization of $360.83 million. Pacific Biosciences, Inc. develops Deoxyribonucleic Acid (DNA) sequencing platform. The Company designs and develops a method for single-molecule DNA sequencing that was developed through collaboration between the research groups of Harold Craighead and Watt Webb at Cornell University, United States.
Why Should Investors Buy PACB After the Recent Fall? Just Go Here and Find Out
PennyStockEarnings.com is keen to discover penny stocks with the potential to make short and long-term gains.
PSE Team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks.
PLEASE NOTE WELL: The employees of PennyStockEarnings.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockEarnings.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockEarnings.com is not offering securities for sale. Neither PennyStockEarnings.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockEarnings.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockEarnings.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer Here: http://www.pennystockearnings.com/disclaimer/
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)